SOPHARMA AD - Notification for acquisition of own shares

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 110 / 2017

Date of issue: 2017-12-07

Short name of the issuer

SOPHARMA AD

Subject

Notification for acquisition of own shares

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Sopharma AD hereby informs that on 6 December 2017 the Company bought 3 061 292 own shares representing 2.271% of the share capital of the Company, at a total value of 13 071 716.84 BGN on the Bulgarian Stock Exchange, the average price per share was 4.27 BGN. The trading of treasury shares is pursuant to decision by the Annual General Meeting of Shareholders from 23 June 2010. The total number of treasury shares after these transactions is 9 146 785, representing 6.786% of the share capital of the Company. With these transactions Sopharma AD passed the threshold of 5% for the treasury shares.

Annexes

File Description

Current report 110 buy back 07122017en.pdf Notification for acquisition of own shares

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2017-12-07 Ognian Donev Executive Director